Skip to main content
Full access
Articles
Published Online: 15 March 2016

Public Stigma in China Associated With Schizophrenia, Depression, Attenuated Psychosis Syndrome, and Psychosis-Like Experiences

Abstract

Objective:

Attenuated psychosis syndrome (APS) has recently been included in the appendix of DSM-5 as a condition for further study. This study compared public stigma associated with four mental health conditions among study participants in Hong Kong.

Methods:

The cross-sectional study involved 204 participants (154 members of the general public general public and 50 health care professionals) recruited through a public awareness campaign and the e-mail network of the University of Hong Kong. Participants read four vignettes describing persons with schizophrenia, depression, APS, or psychosis-like experiences. For each vignette, they used a scale to rate their level of stigma in seven domains: social distance, traditional prejudice, exclusionary sentiments, negative affect, perceptions of dangerousness, treatment carryover, and disclosure carryover. Analyses compared ratings within and across vignettes.

Results:

Schizophrenia received the highest public stigma ratings, followed by APS, depression, and psychosis-like experiences. Total stigma scores were higher for the general public than for health care professionals. Public stigma associated with APS was similar to that associated with depression. Ratings of treatment carryover indicated that participants believed that being known to have received treatment for APS or depression would have lasting consequences.

Conclusions:

Stigma should be considered in the development of mental health services and research in China, particularly in regard to people with schizophrenia and those at risk of psychosis.
Among people with mental illness, stigma has adverse effects in multiple domains—from detection to treatment and recovery (13). Antistigma and public awareness programs have been conducted to minimize the impact of public stigma on patients and their families, but the effectiveness of such programs has been questioned (4,5). With the recent emphasis on detecting and treating individuals in the prodromal phase of psychosis, concerns have been raised about whether stigma would spread to this at-risk population. Attenuated psychosis syndrome (APS), which is characterized by psychosis-like symptoms that are below the threshold for full psychosis, is included in DSM-5 under “conditions for further study.” Scholars continue to debate whether the condition should be classified as a separate diagnostic entity and whether the risk of developing full-blown psychosis and the level of stigma associated with APS are as substantial as they were thought to be (6,7).
Schizophrenia has been viewed as a more stigmatized mental illness than depression (810). Many people believe that schizophrenia is a brain disorder and that it is harder to control, more unpredictable, and more dangerous than depression and less likely to be treated (9,11,12). In contrast, many view depression as easier to control than schizophrenia, more predictable, less dangerous, and more treatable; people are less likely to want to maintain social distance from individuals with depression (13). Severity of symptoms and deviation from normal behavior may also affect stigma (1416).
These explanations of the effects of stigma may apply only when the illness is clearly understood. In the case of APS, people may not fully understand the condition, which may affect their attitude toward the affected individual (17). The symptoms of APS and schizophrenia are similar. Even though APS symptoms are less severe, people might base their understanding of APS on their knowledge of psychosis. This study compared public stigma associated with APS and with schizophrenia, depression, and psychosis-like experiences. We hypothesized that public stigma associated with APS is less than that associated with schizophrenia and similar to that associated with depression and that public stigma is lower among individuals with more education and previous contact with persons with mental disorders.

Methods

Study Design

This cross-sectional study of public stigma used a vignette methodology. A total of 204 Chinese participants were recruited through a public awareness campaign and through the e-mail network of the University of Hong Kong. Individuals age 18 and older who had never had a diagnosis of or treatment for a mental disorder and who consented to participate were included. The study was approved by the Institutional Review Board of the University of Hong Kong/Hospital Authority Hong Kong West Cluster and performed in accordance with ethical standards of the 1964 Declaration of Helsinki and its later amendments. Basic demographic information, including age, gender, current occupation, and education level, was collected. Previous contact with persons with mental illness was also noted on the basis of questions adapted from Alexander and Link (18). Participants read four vignettes describing individuals with APS, schizophrenia, depression, or psychosis-like experiences and responded online. They used a seven-domain stigma scale (SDSS) to rate their level of public stigma associated with each of the four individuals in the vignettes. [The four vignettes are included in an online supplement to this article.]

Measures

Each of the vignettes objectively described symptoms and functioning of the person with the disorder. The schizophrenia and depression vignettes stated the diagnosis and were previously used in study by Pescosolido and colleagues (19). The APS vignette described the likelihood of transition to psychosis as follows: “People at high risk of psychosis have not yet developed a full psychotic disorder but have some symptoms that might lead to a future psychotic disorder. However, only 35% of these individuals will go on to exhibit psychosis within 2.5 years of identification” (20). The vignette on psychosis-like experiences described a person with no psychiatric diagnosis and normal functioning who experienced transient psychotic symptoms. English versions of the Chinese vignettes were back-translated by a professional translator and proved to be satisfactory.
The SDSS is a 27-item questionnaire about public stigma adopted from Pescosolido and colleagues (19). The scale measures seven major domains of public stigma, including social distance, traditional prejudice, exclusionary sentiments, negative affect, perceptions of dangerousness, treatment carryover, and disclosure carryover. Social distance refers to reluctance to interact with members of a group. Traditional prejudice refers to adherence to the belief that all members of a group are categorically inferior to others. Exclusionary sentiment refers to the willingness to exclude people from a group from the full benefits of citizenship. Negative affect refers to public views that people from a group are difficult to interact with. Perception of dangerousness is about the fear that persons from a group represent a threat of violence to self or others. Treatment carryover is the belief that being known to have received mental health care carries long-lasting consequences. Disclosure spillover refers to the negative consequences of revealing one’s mental illness. The SDSS uses a 4-point Likert scale (1, strongly agree; 2, agree; 3, disagree; and 4, strongly disagree) to measure agreement with statements about each vignette. Each domain score was calculated by summing responses from the relevant items and dividing by the total number of items in the domain. Scores above the midpoint (2.0) indicated a stigmatizing attitude, with higher scores indicating more severe public stigma.

Statistical Analyses

Statistical analyses were conducted with SPSS, version 20.0. The Kolmogorov-Smirnov test was used to test for normality of noncategorical variables, and Wilcoxon signed-rank tests were used to examine differences in scores between pairs of vignettes. Kruskal-Wallis or Mann-Whitney tests examined differences in scores between demographic variables.

Results

Demographic Characteristics

As shown in Table 1, 204 participants (154 from the general public and 50 health care professionals) completed the questionnaires. The mean age of the 204 participants was 27.3. Seventy percent were female, and 64% had undergraduate or postgraduate degrees. Most participants did not have relatives or close friends who had been hospitalized in a psychiatric unit. However, about half (43%) had worked or volunteered in mental health services.
TABLE 1. Characteristics of 204 participants in a vignette study of public stigma
CharacteristicN%
Participant group  
 Public15476
 Health care professional5025
Age (M±SD)27.3±10.5 
Gender  
 Male6230
 Female14270
Education level  
 Primary11
 Secondary189
 Diploma5326
 Undergraduate degree7637
 Postgraduate degree5527
 Missing11
First-degree relatives hospitalized  
 Self32
 Parent63
 Children11
 Sibling42
 No18892
 Missing21
Other relative hospitalized  
 Yes2211
 No18088
 Missing21
Close friend or spouse hospitalized  
 Close friend168
 No18691
 Missing21
Worked or volunteered in mental health services  
 Worked5025
 Volunteered3718
 No12159
 Missing2914
Visited psychiatric hospital for purpose other than treatment  
 Yes7436
 No13064
Saw someone in public who seemed mentally ill  
 Often189
 Sometimes14471
 Almost never3618
 Never53
 Missing11

Domain Scores Across Vignettes

As shown in Table 2, total stigma scores were highest for schizophrenia, followed by APS, depression, and psychosis-like experiences. For both schizophrenia and psychosis-like experiences, total stigma scores and all domain scores differed significantly (p<.001) from scores for the other vignettes. For APS and depression, only the domain score for treatment carryover differed significantly.
TABLE 2. Scores of 204 participants on seven domains of public stigma, by mental health conditiona
Total score and domainSchizophreniaAPSDepressionPsychosis-like experiences
MSDMSDMSDMSD
Total score2.45*.432.22.362.10.381.79*.44
Domain        
 Social distance2.53*.582.24.492.08.511.77*.54
 Traditional prejudice2.31*.442.14.452.09.451.81*.59
 Exclusionary sentiments2.20*.951.97.481.96.521.64*.48
 Negative affect2.42*.702.02.572.01.571.64*.52
 Perceptions of dangerousness2.56*.632.38.682.31.551.76*.62
 Treatment carryover2.56*.602.31*.902.15*.641.86*.71
 Disclosure spillover2.61*.452.52.442.34.512.04*.58
a
 APS, attenuated psychosis syndrome. Possible scores range from 1 to 4, with higher scores indicating more severe stigma.
*
p<.001, for difference with scores of all other vignettes
For APS and depression, the order of domains as ranked by score was similar; the domain with the highest score for both vignettes was disclosure spillover, followed by perception of dangerousness, and treatment carryover. For APS, the two domains with the next-highest scores were social distance and traditional prejudice, followed by negative affect and exclusionary sentiments. In contrast, for depression, the two domains with the next-highest scores were traditional prejudice and social distance, also followed by negative affect and exclusionary sentiments. However, there was no significant difference between domain rankings for depression. For schizophrenia, domain rankings were as follows (from highest to lowest score): disclosure spillover, perception of dangerousness, treatment carryover, social distance, negative affect, traditional prejudice, and exclusionary sentiments. Significant differences with other vignettes were noted for social distance (Z=−2.00, p<.05) and negative affect (Z=−1.97, p<.05). For psychosis-like experiences, domain rankings were as follows: disclosure spillover, treatment carryover, traditional prejudice, social distance, dangerousness, exclusionary sentiments. Significant differences with other vignettes were noted for treatment carryover (Z=−2.09, p<.05), and exclusionary sentiments (Z=−2.11, p<.05).

Total Scores Across Vignettes by Characteristic

Table 3 presents total public stigma scores for each vignette by demographic and other characteristics. For the APS vignette, total scores of participants from the general public were higher than scores of health care professionals (Z=−3.0, p<.01); the scores for these two groups did not differ significantly for any other vignette. For the APS vignette, some domain scores (data not shown) were also significantly higher for the public group than for the professional group: social distance (Z=−2.86, p<.01), negative affect (Z=−3.98, p<.001), and perceptions of dangerousness (Z=−2.39, p<.05). No significant differences between rankings were found by gender and age for any vignette.
TABLE 3. Total public stigma scores of 204 participants, by mental health condition and participant characteristica
CharacteristicAPSSchizophreniaDepressionPsychosis-like experiences
MSDMSDMSDMSD
Participant group        
 Public2.27.092.41.112.17.101.86.10
 Professional2.14.062.41.122.11.071.86.10
Gender        
 Male2.19.082.47.072.14.091.92.14
 Female2.22.072.39.112.14.081.83.08
Education level        
 Secondary2.22.152.41.042.26.152.06.17
 Diploma2.49.092.49.052.38.102.17.11
 Undergraduate degree2.17.072.35.132.05.091.74.09
 Postgraduate degree2.19.102.49.112.18.101.96.15
Worked or volunteered in mental health services        
 Work1.95.092.17.211.94.111.58.12
 Volunteer2.23.122.43.232.14.181.96.20
 No2.32.072.52.072.23.081.97.09
Saw someone in public who seemed mentally ill        
 Often2.20.172.83.021.91.311.74.41
 Sometimes2.24.062.48.072.19.071.87.08
 Almost never2.08.132.04.301.97.181.85.17
a
APS, attenuated psychosis syndrome. Possible scores range from 1 to 4, with higher scores indicating more severe stigma.
Significant differences in total stigma scores were found by education level for both the APS and the schizophrenia vignettes. For the APS vignette, participants who had a high school diploma had significantly higher scores than participants in the other education-level groups (χ2=12.8, df=4, p<.05). For the APS vignette, scores in two domains (data not shown) were also significantly higher for those with a high school diploma than for those in the other education-level groups: traditional prejudice (χ2=11.7, df=4, p<.05) and negative affect (χ2=13.0, df=4, p<.05). For the schizophrenia vignette, participants without a high school diploma (secondary level) had significantly higher scores than those in the other education-level groups on one domain: treatment carryover (χ2=11.1, df=4, p<.05).
For all vignettes, total stigma scores of participants who reported working or volunteering in mental health services were significantly lower than total scores of participants who reported no such experiences (Table 3). For the APS vignette, not only did the total stigma score differ between these groups (χ2=24.1, df=2, p<.001), but the scores on five domains (data not shown) also differed: social distance (χ2=25.7, df=2, p<.001), traditional prejudice (χ2=10.2, df=2, p<.01), negative affect (χ2=26.0, df=2, p<.001), perception of dangerousness (χ2=13.2, df=2, p<.001), and treatment carryover (χ2=8.6, df=2, p<.01). For the schizophrenia vignette, scores between the general public and health care professionals differed for two domains: negative affect (χ2=8.0, df=2, p<.05) and treatment carryover (χ2=9.8, df=2, p<.01). For the depression vignette, scores between the two groups differed only for the domain of treatment carryover (χ2=8.9, df=2, p<.05). For the psychosis-like experiences vignette, scores between the two groups differed for two domains: exclusionary sentiments (χ2=8.5, df=2, p<.05) and negative affect (χ2=8.6, df=2, p<.01).
Finally, for the APS vignette, participants who reported encountering someone in public who appeared to be mentally ill either often or sometimes had higher scores on two domains than those who reported almost never having such encounters (data not shown): exclusionary sentiments (χ2=1.0, df=3, p<.05) and negative affect (χ2=15.3, df=3, p<.01).

Discussion

In this cross-sectional study involving 204 participants, we found that the stigma scores of the general public were highest for schizophrenia, followed by APS, depression, and psychosis-like experiences. Of note, stigma scores indicated that APS and depression were perceived similarly by study participants; however, significantly higher scores for APS on the domain of treatment carryover indicated that participants believed that being known to have received treatment for APS would have more lasting consequences than treatment for depression. Demographic and other characteristics appeared to have affected stigma scores for the four mental health conditions, with the largest effects seen for APS. Characteristics that affected stigma included participants’ education level, the frequency with which they encountered in public someone who appeared to be mentally ill, whether or not they were a health care professional, and whether they worked or volunteered in mental health services.
Studying public stigma associated with various mental health conditions is important because stigma can affect help-seeking behavior and recovery. Public stigma associated with APS was found to be weaker than that associated with schizophrenia, whereas stigma associated with APS and depression was similar. This finding suggests that substantial public stigma is associated with APS; being known to have received treatment for APS was perceived as having lasting consequences. The findings also suggest potential stigma reduction strategies; for example, the public should be informed about the high remission rate among individuals who experience psychotic symptoms and the potential for complete recovery. A positive finding is that even though symptoms of APS and schizophrenia have similar presentations, stigma scores were lower for APS. This finding may be related to uncertainty about whether all individuals with APS transition to a full-blown psychotic disorder.
Ranking by score on stigma domains for schizophrenia differed more than for the other conditions. For schizophrenia, higher scores were given to “immediate emotion-focused” domains, such as perceptions of dangerousness, negative affect, and social distance, and scores for “higher-order social values,” such as traditional prejudice, were lower (19,21). This finding may result from differences in how the public perceives the role of biopsychosocial factors in these illnesses. The public may view biopsychosocial factors as playing a larger role in APS and depression, compared with schizophrenia (22). In addition, the public may view the individual affected by APS or depression as being more responsible for having the illness, as reflected in the scores for traditional prejudice and negative affect.
This study had several limitations. First, the study did not assess self-stigma. Second, there was no qualitative investigation of participants’ stigma perceptions, which may have provided additional insight into beliefs held by the general public. Third, the concept of APS is relatively new, and we did not assess public knowledge about APS. Although we provided a working definition of APS for participants, their stigma ratings may also have depended on their previous knowledge or experiences. Fourth, the participants may not have been representative of the larger population. Fifth, although the vignettes were reviewed by local experienced psychiatrists for face validity before use, the validity had not been studied in Chinese culture. Sixth, the 4-point scale may not have been able to distinguish between APS and depression groups. Finally, our study was limited to the investigation of public stigma in the Chinese culture, and generalization to Western cultures may not be feasible. Future studies of APS in countries with different beliefs and cultures are warranted.

Conclusions

This study not only expands literature on public stigma associated with mental illnesses but also contributes to future considerations about whether APS should be a clinical diagnostic category. Understanding how the public perceives APS can inform future research and development of clinical services. Stigma reduction programs should consider ways to increase the public’s contact with persons with mental illness. To alter negative views of mental illness, such programs should provide accurate information about the dangerousness of persons with mental illness and about positive treatment outcomes.

Supplementary Material

File (appi.ps.201500156.ds001.pdf)

References

1.
Hinshaw SP, Cicchetti D: Stigma and mental disorder: conceptions of illness, public attitudes, personal disclosure, and social policy. Development and Psychopathology 12:555–598, 2000
2.
Lundberg B, Hansson L, Wentz E, et al: Are stigma experiences among persons with mental illness, related to perceptions of self-esteem, empowerment and sense of coherence? Journal of Psychiatric and Mental Health Nursing 16:516–522, 2009
3.
Penn DL, Kommana S, Mansfield M, et al: Dispelling the stigma of schizophrenia: II. the impact of information on dangerousness. Schizophrenia Bulletin 25:437–446, 1999
4.
Smith M: Anti-stigma campaigns: time to change. British Journal of Psychiatry. Supplement 55:s49–s50, 2013
5.
Zoppei S, Lasalvia A: Antistigma campaigns: really useful and effective? A critical review of the anti-stigma initiatives conducted in Italy [in Italian]. Rivista di Psichiatria 46:242–249, 2011
6.
Shrivastava A, McGorry PD, Tsuang M, et al: “Attenuated psychotic symptoms syndrome” as a risk syndrome of psychosis, diagnosis in DSM-V: the debate. Indian Journal of Psychiatry 53:57–65, 2011
7.
Yung AR, Woods SW, Ruhrmann S, et al: Whither the attenuated psychosis syndrome? Schizophrenia Bulletin 38:1130–1134, 2012
8.
Kelly CM, Jorm AF: Stigma and mood disorders. Current Opinion in Psychiatry 20:13–16, 2007
9.
Norman RM, Windell D, Manchanda R: Examining differences in the stigma of depression and schizophrenia. International Journal of Social Psychiatry 58:69–78, 2012
10.
Shibre T, Negash A, Kullgren G, et al: Perception of stigma among family members of individuals with schizophrenia and major affective disorders in rural Ethiopia. Social Psychiatry and Psychiatric Epidemiology 36:299–303, 2001
11.
Angermeyer MC, Matschinger H: Public beliefs about schizophrenia and depression: similarities and differences. Social Psychiatry and Psychiatric Epidemiology 38:526–534, 2003
12.
Angermeyer MC, Matschinger H: Labeling—stereotype—discrimination: an investigation of the stigma process. Social Psychiatry and Psychiatric Epidemiology 40:391–395, 2005
13.
Angermeyer MC, Matschinger H: The stigma of mental illness: effects of labelling on public attitudes towards people with mental disorder. Acta Psychiatrica Scandinavica 108:304–309, 2003
14.
Link BG: Understanding labeling effects in the area of mental disorders: an assessment of the effects of expectations of rejection. American Sociological Review 52:96–112, 1987
15.
Mueser KT, Bellack AS, Douglas MS, et al: Prediction of social skill acquisition in schizophrenic and major affective disorder patients from memory and symptomatology. Psychiatry Research 37:281–296, 1991
16.
Penn DL, Guynan K, Daily T, et al: Dispelling the stigma of schizophrenia: what sort of information is best? Schizophrenia Bulletin 20:567–578, 1994
17.
Kaur T, Cadenhead KS: Treatment implications of the schizophrenia prodrome. Current Topics in Behavioral Neurosciences 4:97–121, 2010
18.
Alexander L, Link B: The impact of contact on stigmatizing attitudes toward people with mental illness. Journal of Mental Health 12:271–289, 2003
19.
Pescosolido BA, Medina TR, Martin JK, et al: The “backbone” of stigma: identifying the global core of public prejudice associated with mental illness. American Journal of Public Health 103:853–860, 2013
20.
Yung AR, Yuen HP, Berger G, et al: Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk? Schizophrenia Bulletin 33:673–681, 2007
21.
Connolly T, Williams J, Scior K: The effects of symptom recognition and diagnostic labels on public beliefs, emotional reactions, and stigma [corrected] associated with intellectual disability. American Journal on Intellectual and Developmental Disabilities 118:211–223, 2013
22.
Stuart H: Fighting the stigma caused by mental disorders: past perspectives, present activities, and future directions. World Psychiatry 7:185–188, 2008

Information & Authors

Information

Published In

Go to Psychiatric Services
Go to Psychiatric Services

Cover: Anniversary Tin: Candelabra, anonymous artist, ca. 1880–1900. Tin with sand-weighted base. Collection American Folk Art Museum, New York City. Gift of Mr. and Mrs. James D. Clokey, III, 1984.29.1A. Photo: John Parnell. Photo credit: American Folk Art Museum, Art Resource, New York City.

Psychiatric Services
Pages: 766 - 770
PubMed: 26975519

History

Received: 22 April 2015
Revision received: 15 September 2015
Accepted: 26 October 2015
Published online: 15 March 2016
Published in print: July 01, 2016

Authors

Details

Edwin Ho-Ming Lee, M.B.Ch.B., M.Sc.
The authors are with the Department of Psychiatry, University of Hong Kong, China (e-mail: [email protected]).
Christy Lai-Ming Hui, Ph.D.
The authors are with the Department of Psychiatry, University of Hong Kong, China (e-mail: [email protected]).
Elaine Yee-Ning Ching, M.Sc.
The authors are with the Department of Psychiatry, University of Hong Kong, China (e-mail: [email protected]).
Jingxia Lin, Ph.D.
The authors are with the Department of Psychiatry, University of Hong Kong, China (e-mail: [email protected]).
Wing-Chung Chang, M.B.Ch.B.
The authors are with the Department of Psychiatry, University of Hong Kong, China (e-mail: [email protected]).
Sherry Kit-Wa Chan, M.B.B.S., M.Phil.
The authors are with the Department of Psychiatry, University of Hong Kong, China (e-mail: [email protected]).
Eric Yu-Hai Chen, M.D.
The authors are with the Department of Psychiatry, University of Hong Kong, China (e-mail: [email protected]).

Competing Interests

The authors report no financial relationships with commercial interests.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Psychiatric Services

PPV Articles - Psychiatric Services

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share